| Trial ID: | L0906 |
| Source ID: | NCT00211978
|
| Associated Drug: |
Calcium Acetate
|
| Title: |
EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hyperphosphatemia|Kidney Failure
|
| Interventions: |
DRUG: calcium acetate|DRUG: placebo
|
| Outcome Measures: |
Primary: serum phosphorus, weeks 5-24 | Secondary: calcium x phosphorus product, weeks 5-24|intact parathyroid hormone, weeks 5-24
|
| Sponsor/Collaborators: |
Sponsor: Nabi Biopharmaceuticals
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
110
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-05
|
| Completion Date: |
2006-10
|
| Results First Posted: |
|
| Last Update Posted: |
2008-01-08
|
| Locations: |
University of Texas Health Sciences Center, San Antonio, Texas, 78229-3900, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00211978
|
